Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
14.99
+0.88 (6.24%)
At close: Dec 20, 2024, 4:00 PM
15.11
+0.12 (0.80%)
After-hours: Dec 20, 2024, 5:39 PM EST
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $1.75 billion as of December 20, 2024. Its market cap has increased by 744.97% in one year.
Market Cap
1.75B
Enterprise Value
1.63B
1-Year Change
744.97%
Ranking
Category
Stock Price
$14.99
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $1.75B, an increase of 124.35%. That is a compound annual growth rate of 17.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 1.75B | 475.52% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | 1.23B | 56.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celldex Therapeutics | 1.68B |
| Xencor | 1.68B |
| Dynavax Technologies | 1.68B |
| Integra LifeSciences Holdings | 1.68B |
| Fortrea Holdings | 1.66B |
| 10x Genomics | 1.65B |
| Clover Health Investments | 1.60B |
| Teladoc Health | 1.54B |